Heidelberg Pharma AG

Director's Dealing • Aug 5, 2010

News Details

Directors’ Dealings | 5 August 2010 11:21

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Company: dievini Hopp BioTech Holding GmbH & Co. KG Person performing managerial responsibilities, triggering the disclosure requirement for the legal person Details of the person performing managerial responsibilities Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: no par value bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Purchase Date: 30.07.2010 Price: 4.10 Currency: EUR No. of items: 875338 Total amount traded: 3588885.80 Place: außerbörslich/OTC Explanation for publication: Subscription in the rights issue Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 05.08.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 11709